acetylcarnitine has been researched along with Heart Failure in 5 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A panel of gut-related biomarkers including metabolites of the choline/carnitine- pathway (acetyl-L-carnitine, betaine, choline, γ-butyrobetaine, L-carnitine and trimethylamine-N-oxide [TMAO]) and the gut peptide, Trefoil factor-3 (TFF-3), were investigated in 1,783 patients with worsening HF enrolled in the systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF) cohort and associations with HF severity and outcomes, and use in risk stratification were assessed." | 4.12 | Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium. ( Anker, SD; Cleland, JG; Israr, MZ; Lang, CC; Metra, M; Ng, LL; Salzano, A; Samani, NJ; Suzuki, T; van Veldhuisen, DJ; Voors, AA; Zannad, F; Zhan, H, 2022) |
| "Trimethylamine N-oxide (TMAO), a gut-related metabolite, is associated with heart failure (HF) outcomes." | 4.02 | Association of gut-related metabolites with outcome in acute heart failure. ( Bernieh, D; Cassambai, S; Heaney, LM; Israr, MZ; Jones, DJL; Ng, LL; Salzano, A; Suzuki, T; Yazaki, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Israr, MZ | 2 |
| Zhan, H | 1 |
| Salzano, A | 2 |
| Voors, AA | 1 |
| Cleland, JG | 1 |
| Anker, SD | 1 |
| Metra, M | 1 |
| van Veldhuisen, DJ | 1 |
| Lang, CC | 1 |
| Zannad, F | 1 |
| Samani, NJ | 1 |
| Ng, LL | 2 |
| Suzuki, T | 2 |
| Bernieh, D | 1 |
| Cassambai, S | 1 |
| Yazaki, Y | 1 |
| Heaney, LM | 1 |
| Jones, DJL | 1 |
| Magiera, S | 1 |
| Baranowska, I | 1 |
| Kusa, J | 1 |
| Baranowski, J | 1 |
| Han, BJ | 2 |
| Liu, HP | 1 |
| Tang, YZ | 2 |
| Wan, BS | 2 |
| Zhou, EF | 2 |
| Liang, KJ | 1 |
5 other studies available for acetylcarnitine and Heart Failure
| Article | Year |
|---|---|
Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium.
Topics: Acetylcarnitine; Biomarkers; Carnitine; Choline; Chronic Disease; Heart Failure; Humans | 2022 |
Association of gut-related metabolites with outcome in acute heart failure.
Topics: Acetylcarnitine; Acute Disease; Aged; Aged, 80 and over; Betaine; Carnitine; Choline; Female; Gastro | 2021 |
A liquid chromatography and tandem mass spectrometry method for the determination of potential biomarkers of cardiovascular disease.
Topics: Acetylcarnitine; Biomarkers; Carnitine; Case-Control Studies; Chromatography, High Pressure Liquid; | 2013 |
[Effects of acetylcarnitine and carnitine on experimental heart failure].
Topics: Acetylcarnitine; Animals; Carnitine; Dogs; Drug Synergism; Female; Heart Failure; Hemodynamics; Male | 1986 |
[Comparative study on the effect of acetylcarnitine and carnitine on experimental hypoxic heart failure and their interactions with strophanthin K].
Topics: Acetylcarnitine; Animals; Carnitine; Drug Synergism; Guinea Pigs; Heart Failure; Hypoxia; In Vitro T | 1985 |